» Articles » PMID: 27462005

Stable Preparations of Tyrosine Hydroxylase Provide the Solution Structure of the Full-length Enzyme

Overview
Journal Sci Rep
Specialty Science
Date 2016 Jul 28
PMID 27462005
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Tyrosine hydroxylase (TH) catalyzes the rate-limiting step in the biosynthesis of catecholamine neurotransmitters. TH is a highly complex enzyme at mechanistic, structural, and regulatory levels, and the preparation of kinetically and conformationally stable enzyme for structural characterization has been challenging. Here, we report on improved protocols for purification of recombinant human TH isoform 1 (TH1), which provide large amounts of pure, stable, active TH1 with an intact N-terminus. TH1 purified through fusion with a His-tagged maltose-binding protein on amylose resin was representative of the iron-bound functional enzyme, showing high activity and stabilization by the natural feedback inhibitor dopamine. TH1 purified through fusion with a His-tagged ZZ domain on TALON is remarkably stable, as it was partially inhibited by resin-derived cobalt. This more stable enzyme preparation provided high-quality small-angle X-ray scattering (SAXS) data and reliable structural models of full-length tetrameric TH1. The SAXS-derived model reveals an elongated conformation (Dmax = 20 nm) for TH1, different arrangement of the catalytic domains compared with the crystal structure of truncated forms, and an N-terminal region with an unstructured tail that hosts the phosphorylation sites and a separated Ala-rich helical motif that may have a role in regulation of TH by interacting with binding partners.

Citing Articles

Assessment of the neuroprotective effect of green synthesized iron oxide nanoparticles capped with curcumin against a rat model of Parkinson's disease.

Khadrawy Y, Hosny E, Eldein Mohamed H Iran J Basic Med Sci. 2024; 27(1):81-89.

PMID: 38164480 PMC: 10722487. DOI: 10.22038/IJBMS.2023.73124.15892.


Pathogenic Impact of Fatty Acid-Binding Proteins in Parkinson's Disease-Potential Biomarkers and Therapeutic Targets.

Kawahata I, Fukunaga K Int J Mol Sci. 2023; 24(23).

PMID: 38069360 PMC: 10707307. DOI: 10.3390/ijms242317037.


Structural mechanism for tyrosine hydroxylase inhibition by dopamine and reactivation by Ser40 phosphorylation.

Bueno-Carrasco M, Cuellar J, Flydal M, Santiago C, Krakenes T, Kleppe R Nat Commun. 2022; 13(1):74.

PMID: 35013193 PMC: 8748767. DOI: 10.1038/s41467-021-27657-y.


Personalized Medicine to Improve Treatment of Dopa-Responsive Dystonia-A Focus on Tyrosine Hydroxylase Deficiency.

Nygaard G, Szigetvari P, Grindheim A, Ruoff P, Martinez A, Haavik J J Pers Med. 2021; 11(11).

PMID: 34834538 PMC: 8625014. DOI: 10.3390/jpm11111186.


Relevance of Electrostatics for the Interaction of Tyrosine Hydroxylase with Porous Silicon Nanoparticles.

Bezem M, Johannessen F, Krakenes T, Sailor M, Martinez A Mol Pharm. 2021; 18(3):976-985.

PMID: 33417459 PMC: 7927144. DOI: 10.1021/acs.molpharmaceut.0c00960.


References
1.
Arturo E, Gupta K, Heroux A, Stith L, Cross P, Parker E . First structure of full-length mammalian phenylalanine hydroxylase reveals the architecture of an autoinhibited tetramer. Proc Natl Acad Sci U S A. 2016; 113(9):2394-9. PMC: 4780608. DOI: 10.1073/pnas.1516967113. View

2.
Goodwill K, Sabatier C, Marks C, Raag R, FITZPATRICK P, Stevens R . Crystal structure of tyrosine hydroxylase at 2.3 A and its implications for inherited neurodegenerative diseases. Nat Struct Biol. 1997; 4(7):578-85. DOI: 10.1038/nsb0797-578. View

3.
Blanchet C, Spilotros A, Schwemmer F, Graewert M, Kikhney A, Jeffries C . Versatile sample environments and automation for biological solution X-ray scattering experiments at the P12 beamline (PETRA III, DESY). J Appl Crystallogr. 2015; 48(Pt 2):431-443. PMC: 4379436. DOI: 10.1107/S160057671500254X. View

4.
Fitzpatrick P . Structural insights into the regulation of aromatic amino acid hydroxylation. Curr Opin Struct Biol. 2015; 35:1-6. PMC: 4688188. DOI: 10.1016/j.sbi.2015.07.004. View

5.
Petoukhov M, Svergun D . Global rigid body modeling of macromolecular complexes against small-angle scattering data. Biophys J. 2005; 89(2):1237-50. PMC: 1366608. DOI: 10.1529/biophysj.105.064154. View